Purple Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Purple Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Purple Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Purple Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Purple Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Purple Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Purple Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Purple Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Purple Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Purple Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Purple Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Purple Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Purple Biotech | F-1: Registration statement for securities of certain foreign private issuers
Purple Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Purple Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Purple Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Purple Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Purple Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Purple Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
Purple Biotech | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
No Data
No Data